Study to Evaluate Markers of Response in Locally Advanced Breast Cancer
NCT01338753
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
74
Enrollment
OTHER
Sponsor class
Conditions
Breast Neoplasms
Interventions
OTHER:
Bevacizumab, docetaxel and doxorubicin followed by surgery
Sponsor
Clinica Universidad de Navarra, Universidad de Navarra
Collaborators
[object Object]